- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
- 10-Q Quarterly report
- 4 Stock Option Agreement
- 4 2015 Stock Option Plan
- 31 Certification of Principal Executive Officer Pursuant to Section 302
- 31 Certification of Chief Financial Officer Pursuant to Section 302
- 32 Certification of Principal Executive Officer Pursuant to Section 906
- 32 Certification of Chief Financial Officer Pursuant to Section 906
- Download Excel data file
- View Excel data file
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADDED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Repro Med Systems, Inc. (the “Company”) on Form 10-Q (the “Report”) for the period ending August 31, 2015 as filed with the Securities and Exchange Commission, I, Andrew I. Sealfon, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
|
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in this report. |
Date: October 2, 2015
/s/ Andrew I. Sealfon
Andrew I. Sealfon
Principal Executive Officer